Wei G. Su

No. 8 Jiangtan Road
Baoji, 721008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Targeting Lactobacillus johnsonii to reverse chronic kidney disease.

Targeting Lactobacillus johnsonii to reverse chronic kidney disease.

Journal: Signal transduction and targeted therapy

Published: November 27, 2023

Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway.

Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway.

Journal: Acta pharmacologica Sinica

Published: May 25, 2023

Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites.

Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites.

Journal: British journal of pharmacology

Published: February 28, 2023

Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy.

Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy.

Journal: Free radical biology & medicine

Published: January 06, 2023

1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway.

1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway.

Journal: British journal of pharmacology

Published: May 10, 2021

Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Journal: British journal of pharmacology

Published: December 14, 2019

Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria.

Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: March 19, 2019

microRNAs in chronic kidney disease.

microRNAs in chronic kidney disease.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 13, 2018

Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.

Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.

Journal: Advances in clinical chemistry

Published: April 16, 2018

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.

Journal: Nature communications

Published: April 13, 2018

Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.

Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.

Journal: Clinical biochemistry

Published: May 31, 2017

Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.

Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.

Journal: Journal of proteome research

Published: March 14, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026